Ketamine in cancer pain: An update

Palliative Medicine

Volumn 10, Issue 3, 1996, Pages 225-230

  Mercadante, Sebastiano ^a,b  

^a Buccheri La Ferla Hospital   (Italy)

^b SAMOT Onlus   (Italy)

Author keywords

Cancer pain; Ketamine; Neuropathic pain; NMDA receptors; Opioids

Indexed keywords

ANESTHETIC AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE;

ANALGESIA; ARTICLE; CANCER PAIN; DRUG BIOAVAILABILITY; DRUG POTENTIATION; DRUG TOLERABILITY; HUMAN; MENTAL DISEASE; NEUROPATHY; ORAL DRUG ADMINISTRATION; RECTAL DRUG ADMINISTRATION; SKIN MANIFESTATION;

ANALGESICS, OPIOID; BIOLOGICAL AVAILABILITY; DRUG SYNERGISM; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; NEOPLASMS; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030056671     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Domino EF, Chodoff P, Corssen G. Pharmacologic effects of Cl-581, a new dissociative anesthetic in man. Clin Pharmacol Ther 1965; 6: 279-91.
2. Cartwright PD, Pingel SM. Midazolam and diazepam in ketamine anaesthesia. Anaesthesia 1984; 59: 439-42.
3. Slogoff S, Allen GW, Wessels LV, Cheney DH. Clinical experience with subanesthetic ketamine. Anesth Analg 1974; 53: 354-58.
4. Sadove MS, Shulman M, Hatano S, Fevold N. Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg 1971; 50: 452-57.
5. Grant IS, Nimmo WS, Clements JA. Pharmacakinetics and analgesic effects of IM and oral ketamine. Br J Anaesth 1981; 53: 805-10.
6. Clement JA, Nimma WS. Pharmacokinetics and analgesic effects of ketamine in man. Br J Anaesth 1981; 53: 27-30.
7. Pedraz JL, Calvo MB, Lanao JM, Muriel C, Santos Lamas J, Dominguez-Gil A. Pharmacokinetics of rectal ketamine in children. Br J Anaesth 1989; 63: 671-74.
8. Jantzen JP, Erdmann K, Hilley D, Klein AM. Comparative study of analgesia and plasma levels following rectal, intramuscular and intravenous administration of ketamine. Anaesthetist 1985; 34: 346-51.
9. Cook DR, Stiller R, Dayton P. Pharmacokinetics of ketamine in infants and small children. Anesthesiology 1982; 57: A428.
10. Gutstein HB, Johnson KL, Heard MB, Gregory GA. Oral ketamine preanesthetic medication in children. Anesthesiology 1992; 76: 28-33.
11. Morqan AJ, Dutkiewicz TWS. Oral ketamine. Anaesthesia 1983; 38: 293.
12. Idvall J, Holasek J, Stenberg P. Rectal ketamine for induction of anaesthesia in children. Anaesthesia 1983; 38: 60-64.
13. Malaquin JM. Ketamine par voie rectale pour l' induction de l'anesthésie pédiatrique. Can J Anesth 1984; 32: 373-74.
14. Weksler N, Ovadia L, Muati G, Stav A. Nasal ketamine for paediatric premedication. Can J Anaesth 1993; 40: 119-21.
15. Fink AD, Nagai SH. A possible mechanism of ketamine-induced anesthesia. Anesthesiology 1982; 56: 291-97.
16. Fratta W, Casu M, Balistreri A, Boviselli A, Biggio G, Gessa GL. Failure of ketamine to interact with opiate receptors. Eur J Pharmacol 1980; 61: 389-91.
17. Stella L, Crescenti A, Torri G. Effect of naloxone on the loss of consciousness induced by IV anaesthetic agents in man. Br J Anaesth 1984; 56: 369-73.
18. Woolf CJ. Recent advances in the pathiophysiology of acute pain. Br J Anaesth 1989; 63: 139-46.
19. Yamamoto T, Yakch TL. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain 1992; 49: 121-28.
20. Coderre TJ, Katz J, Vaccarino AL, Mekack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259-85.
21. Dickenson AH, Sullivan AF. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurons in the rat. Brain Res 1990; 506: 31-39.
22. MacDermott AB, Mayer ML, Westbrook GI, Smith SJ, Barker JL. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 1986; 321: 519-22.
23. Minami T, Nishihara I, Ito S, Sakamoto K, Hyodo M, Hayhaishi O. Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2a in conscious mice. Pain 1995; 61: 285-90.
24. Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 1994; 56: 69-75.
25. Backonja M, Arndt G, Gomabr KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
26. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989; 36: 186-97.
27. Sosnowski M, Lossignol D, Fodderie L. Reversibility of opioid insensitive pain. 7th World Congress on Pain, August 22-27 1993, Abstract p16
28. Ogawa S, Kanamaru T, Noda K, Saeh S, Katsumata N, Kato J, Nakamura T, Saito H, Suzuki H. Intravenous microdrip infusion of ketamine in subanaesthetic doses for intractable terminal cancer pain. Pain Clin 1994; 7: 125-29.
29. Oshima F, Tei K, Kayazawa H, Urabe N. Continuous subcutaneous injection of ketamine for cancer pain. Can J Anaesth 1990; 37: 385-92.
30. Luczak J, Okupny M, Sopata M. The use of ketamine in the palliative care. Paper presented at the advanced Palliative Care Course, Lad, Poland, 1992.
31. Laird D, Lovel T. Paradoxical pain. Lancet 1993; 341: 241.
32. Twycross R. Pain relief in advanced cancer. London: Pittman Books Limited, 1994, 476-79.
33. Clark JL, Kalan GE. Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J Pain Symptom Manage 1995; 10: 310-14.
34. Mercadante S, Lodi F, Sapio M, Caligara M. Long term ketamine subcutaneous continuous infusion in neuropathic cancer pain: case report. J Pain Symptom Manage 1995; 10: 564-68.
35. Edmonds P, Davis C. Experience of the use of subcutaneous ketamine in patients with cancer-related neuropathic pain. Eur J Palliat Care. Abstracts of the 4th Congress of the European Association for Palliative Care, Barcelona 6-9 December 1995, pp 68.